90 Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple...
90 Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
About this item
Full title
Author / Creator
Tuazon, Sherilyn A , Sandmaier, Brenda M , Gooley, Theodore A , Fisher, Darrell R , Holmberg, Leona A , Becker, Pamela S , Lundberg, Sally J , Orozco, Johnnie J , Gopal, Ajay K , Till, Brian G , Coffey, David G , Nartea, Margaret E , Matesan, Manuela C , Pagel, John M , Rajendran, Joseph G , Press, Oliver W , Bensinger, William I and Green, Damian J
Publisher
England
Journal title
Language
English
Formats
Publication information
Publisher
England
Subjects
More information
Scope and Contents
Contents
To improve disease control without increasing the toxicity of a reduced-intensity allogeneic hematopoietic cell transplantation (HCT) in multiple myeloma (MM), a phase I trial was performed using an antibody-radionuclide conjugate targeting CD45 (
Y-DOTA-BC8) as conditioning.
Y-DOTA-BC8 was combined with fludarabine and low-dose TBI followed...
Alternative Titles
Full title
90 Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
Authors, Artists and Contributors
Author / Creator
Sandmaier, Brenda M
Gooley, Theodore A
Fisher, Darrell R
Holmberg, Leona A
Becker, Pamela S
Lundberg, Sally J
Orozco, Johnnie J
Gopal, Ajay K
Till, Brian G
Coffey, David G
Nartea, Margaret E
Matesan, Manuela C
Pagel, John M
Rajendran, Joseph G
Press, Oliver W
Bensinger, William I
Green, Damian J
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_32710011
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32710011
Other Identifiers
E-ISSN
1476-5365
DOI
10.1038/s41409-020-01000-3
